AVENues Seeks Submissions for May/June Issue
- Details
- Category: News
- Published on Thursday, 01 March 2012 14:13
- Written by Lara Landis
- Hits: 347
Avenues, a PDF publication put out by the Asexual Visibility and Education Network, released another call for submissions. Submissions cover news, reviews, editorials, entertainment and lifestyle pieces.
Northern Illinois University Conducts Survey About Asexual Relationships
- Details
- Category: News
- Published on Monday, 27 February 2012 20:58
- Written by Lara Landis
- Hits: 584
A Northern Illinois University seeks information and data about the formation and development of Asexual relationships. The researcher made the request through AVEN’s project team research contact.
Read more: Northern Illinois University Conducts Survey About Asexual Relationships
New Zealand Asexuals Wanted for 20/20 New Zealand Story
- Details
- Category: News
- Published on Friday, 24 February 2012 14:11
- Written by CF_Asexual
- Hits: 424
Despite an openly Asexual character on a New Zealand soap opera, Asexuality is still a little discussed subject in New Zealand.
Read more: New Zealand Asexuals Wanted for 20/20 New Zealand Story
AVEN Project Team Thanks Jenni GoodChild, Boyfriend For Appearance on How Sex Works
- Details
- Category: News
- Published on Sunday, 26 February 2012 19:56
- Written by Lara Landis
- Hits: 628
AVEN's UK media contact recently asked Asexuals who responded to a blog article and other Internet items responding to the episode of How Sex Works featuring Jenni Goodchild and her boyfriend. Michaeld let AVEN members who responded to his thread know that he had drafted a letter of thanks.
Read more: AVEN Project Team Thanks Jenni GoodChild, Boyfriend For Appearance on How Sex Works
S1 Pharmaceuticals Inc Developing Another HSDD Drug
- Details
- Category: News
- Published on Thursday, 23 February 2012 19:05
- Written by Lara Landis
- Hits: 490
Biosante’s Libigel may or may not be approved by the FDA. Even though the outlook looks bleak for the testosterone gel, drug makers have not given up on their attempt to produce a ‘female Viagra’.
S1 Pharmaceuticals, Incorporated submitted an investigative new drug application to the Food and Drug Administration. The proposed new drug, Lorexys, works on the central nervous system. Researchers hope that the drug will work with the central nervous system to improve the symptoms of HSDD and Female Sexual Dysfunction.
Read more: S1 Pharmaceuticals Inc Developing Another HSDD Drug